ASB7 抗体 (AA 1-274)
Quick Overview for ASB7 抗体 (AA 1-274) (ABIN7144195)
抗原
See all ASB7 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-274
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human Ankyrin repeat and SOCS box protein 7 protein (1-274AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - ASB7 (Ankyrin Repeat and SOCS Box Containing 7 (ASB7))
- 
                                            别名
- ASB7
- 
                                            背景
- 
                        Background: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Aliases: ASB7Ankyrin repeat and SOCS box protein 7 antibody, ASB-7 antibody 
- 
                                            UniProt
- Q9H672
 抗原
- 
                    
 
                                     
                                     
                                    